Company
Ncardia (Pluriomics)
- Business model
- B2B
Record updated 28 September 2026
About
Pluriomics focusses on the development of fully functional human assay systems for use in drug discovery and development. Based on their novel proprietary methods for differentiation of stem cells, the company develops highly functional cell types like the Pluricyte Cardiomyocytes which are used in combination with phenotypic assays to deliver high quality results.